Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Efficacy and Intermediate Endpoint Assays
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Elderly Immune Response to Pneumococcal Polysaccharide
Clinical Relevance of Transient Nevirapine Resistance
Regulation of NRAMP1 Mediated Iron Transport
Acute Support for Long Term Respiratory, Cardiac, and Cardiopulmonary Failure
Provide Data Processing Support for the Diabetes in Ear
Recently added grants:
Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease
S-nitrosation in cell survival and cell death
Molecular control of cardiac regenerative potential
Enhancing Cardiopoietic Regeneration for Ischemic Cardiomyopathy
Sigmar1 in lipid metabolism
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN43309-8-0-1
Application #
7587179
Study Section
Project Start
2004-05-15
Project End
2009-05-14
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Preclinical Efficacy and Intermediate Endpoint Assays
/ Fox Chase Cancer Center
$2,364,525
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Biomarker Assays
Clapper, Margie /
$1,632,611
NIH 2007
N01 CA
Preclinical Efficacy and Intermediate Endpoint Assays
/
Comments
Be the first to comment on this grant